Entrada Therapeutics press release ( TRDA ): Q1 GAAP EPS of -$0.95. Revenue of $0.9M. Net Loss: Net loss was $39.7 million for the first quarter of 2026, compared to $17.3 million for the same period in 2025. More on Entrada Therapeutics Seeking Alpha’s Quant Rating on Entrada Therapeutics Historical earnings data for Entrada Therapeutics Financial information for Entrada Therapeutics
Entrada Therapeutics press release ( TRDA ): Q1 GAAP EPS of -$0.95. Revenue of $0.9M. Net Loss: Net loss was $39.7 million for the first quarter of 2026, compared to $17.3 million for the same period in 2025. More on Entrada Therapeutics Seeking Alpha’s Quant Rating on Entrada Therapeutics Historical earnings data for Entrada Therapeutics Financial information for Entrada Therapeutics
The late playwright was also a great actor and pianist who combined all three talents in Chasing the Moment, which flowed like real life Jack Shepherd’s plays have such an easy way of doing things, a kind of structure I really hadn’t experienced before. I had seen and admired him directing his own play, In Lambeth, in 1989 at the Donmar Warehouse. So, in a spirit of entrepreneurship after we set u...
The late playwright was also a great actor and pianist who combined all three talents in Chasing the Moment, which flowed like real life Jack Shepherd’s plays have such an easy way of doing things, a kind of structure I really hadn’t experienced before. I had seen and admired him directing his own play, In Lambeth, in 1989 at the Donmar Warehouse. So, in a spirit of entrepreneurship after we set up Southwark Playhouse in London in 1993, I asked him to come on board. He gave us – and acted in – Chasing the Moment. What you see in the play is a group of jazz players arriving one at a time into the basement of a pub. The pianist is there already, this old geezer from Leeds called Les. Jack, who sadly died in November, was a pianist himself – he always played Les. Then we’re waiting for the old, slightly drugged up double bass player. His instrument is bigger than he is, coming down the stairs is slow. Then the drummer and his kit arrive, one piece at a time. Continue reading...
Eoneren/E+ via Getty Images Investment Approach Fidelity® Floating Rate High Income Fund is a diversified leveraged-loan strategy focused on investing primarily in loans that banks have made to non-investment-grade companies. We apply a core investment approach, with the majority of the fund concentrated in securities rated B and BB – the heart of the leveraged-loan market – and below-benchmark ex...
Eoneren/E+ via Getty Images Investment Approach Fidelity® Floating Rate High Income Fund is a diversified leveraged-loan strategy focused on investing primarily in loans that banks have made to non-investment-grade companies. We apply a core investment approach, with the majority of the fund concentrated in securities rated B and BB – the heart of the leveraged-loan market – and below-benchmark exposure to the more opportunistic, lower-rated (CCC or below) credit tiers. In particular, we seek companies with strong balance sheets and collateral coverage, high free cash flow, manageable capital structures and improving credit profiles. In doing so, we take a longer-term investment outlook, with an eye to where we are in the credit cycle. We strive to uncover these companies through in-depth fundamental credit analysis, working in concert with Fidelity's high-income and global research teams, with the goal of achieving competitive risk-adjusted returns over a full credit cycle. Loan Market Review Leveraged loans returned -0.67% in the first quarter, as measured by the Morningstar LSTA US Performing Loans Index. With this result, the asset class performed roughly in line with investment-grade and high-yield corporate credit. Loans experienced their shakiest start to a year since 2020, hampered by volatility among issuers in the software industry, along with weak investor demand. After a punishing February, the asset class rebounded in March, gaining 0.54%, as buyers tentatively waded into industries disrupted by concerns about the potential impact of artificial intelligence on software companies with questionable credit fundamentals. Credit spreads widened markedly across the ratings spectrum in February and March, reflecting investor concern with not only software issuers but also geopolitical stress and deteriorating sentiment toward the economic backdrop. Within this more risk-averse environment, higher-quality credits rated BB significantly outperformed, gaining 0.4...
Check out the companies making the biggest moves in premarket trading: Shake Shack — Shares tumbled 17% after the burger chain's first-quarter results fell short of expectations and it reported an operating loss of $2.6 million. Shake Shack's earnings per share broke even, versus earnings of 12 cents a share expected from analysts polled by LSEG. Revenue came in at $366.7 million, versus the $372 ...
Check out the companies making the biggest moves in premarket trading: Shake Shack — Shares tumbled 17% after the burger chain's first-quarter results fell short of expectations and it reported an operating loss of $2.6 million. Shake Shack's earnings per share broke even, versus earnings of 12 cents a share expected from analysts polled by LSEG. Revenue came in at $366.7 million, versus the $372 million consensus estimate. McDonald's — The fast-food chain posted a beat on both the top and bottom line, sending shares nearly 3.2% higher. Adjusted earnings came in at $2.83 per share, versus the $2.74 a share expected from analysts polled by LSEG. Revenue was $6.52 billion, compared to the $6.47 billion consensus estimate. Whirlpool — The manufacturer of household appliances lost 18% after it slashed guidance for the full year. Whirlpool now sees adjusted earnings ranging from $3 to $3.50 per share on revenue of roughly $15 billion. Previously, the company guided for $6 per share and $15.3 billion to $15.6 billion. The company also said in a regulatory filing that "War in Iran resulted in recession-level industry decline in the U.S. as consumer confidence collapsed in late February and March." Shell — U.S.-listed shares of the British energy company shed 1.8%. Shell reported stronger-than-expected first quarter profit and cut the pace of its quarterly share buyback to $3 billion from $3.5 billion. Oil prices, which had surged during the Iran conflict, have dropped below $100. Carlyle Group — The private-equity firm shed 3.5% after reporting after-tax distributable earnings of 89 cents per share for the first quarter, short of the 93 cent FactSet consensus estimate. Carlyle also posted a drop in revenue from a year prior. Tapestry — The Coach parent's fiscal third-quarter results beat Wall Street's estimates, sending the stock 3% higher. It reported adjusted earnings of $1.66 per share, compared to the LSEG consensus estimate of $1.30 a share. Its revenue of $1.92 billi...
An historic surge in US stocks has pushed equities to fresh highs, yet signs of overheating sentiment suggest that the rally may be entering a slower phase. The rebound from the March lows, fueled in part by hopes of easing tensions between the US and Iran and a surge in corporate earnings , has lifted investor sentiment toward what a quantitative model from Bloomberg Intelligence strategists sugg...
An historic surge in US stocks has pushed equities to fresh highs, yet signs of overheating sentiment suggest that the rally may be entering a slower phase. The rebound from the March lows, fueled in part by hopes of easing tensions between the US and Iran and a surge in corporate earnings , has lifted investor sentiment toward what a quantitative model from Bloomberg Intelligence strategists suggests is “manic” territory. The model tracks six components, and three of them have driven it toward that level: high-yield corporate bond spreads, low volatility, and pairwise correlations. That doesn’t necessarily mean a crash is coming: The backdrop has typically coincided with further gains, albeit at a more modest rate. From 2012 through 2023, the Russell 3000 Index delivered an average return of 2.9% in the three months following repeated elevated sentiment readings, according to BI’s Market Pulse model. During those periods, large-cap stocks tended to outperform, with the S&P 500 beating the small-cap Russell 2000 by about 178 basis points. Still, the current episode stands apart from past surges. Historically, outsized monthly gains of this magnitude have tended to follow deep market drawdowns, such as in April 2009 and April 2020, when equities rebounded from crisis-driven lows. This time, stocks rallied to record highs from an already elevated base, a dynamic that could limit future upside. “When everything works at once — growth over value, cyclicals over defensives — it’s usually a late-stage tell, not a fresh start,” BI’s Christopher Cain and Nathaniel Welnhofer wrote. “History says returns can still be positive, just less rewarding, with leadership narrowing back to large caps.” Read More: Cheap and Easy Days Are Done After One of S&P 500’s Best Months The S&P 500 climbed more than 10% in April, marking its fifth-best monthly performance in the past 35 years and pushing the benchmark to fresh all-time highs. It’s already tacked on another 2.2% less than a week ...
Monte Rosa Therapeutics press release ( GLUE ): Q1 Net loss was $44.5 million Revenue of $4.21M (-95.0% Y/Y) misses by $7.18M . More on Monte Rosa Therapeutics Monte Rosa Therapeutics, Inc. (GLUE) Presents at AACR Annual Meeting 2026 - Slideshow Monte Rosa Therapeutics reports Q4 results Monte Rosa rises on J&J collaboration for cancer therapy trial Seeking Alpha’s Quant Rating on Monte Rosa Thera...
Monte Rosa Therapeutics press release ( GLUE ): Q1 Net loss was $44.5 million Revenue of $4.21M (-95.0% Y/Y) misses by $7.18M . More on Monte Rosa Therapeutics Monte Rosa Therapeutics, Inc. (GLUE) Presents at AACR Annual Meeting 2026 - Slideshow Monte Rosa Therapeutics reports Q4 results Monte Rosa rises on J&J collaboration for cancer therapy trial Seeking Alpha’s Quant Rating on Monte Rosa Therapeutics Historical earnings data for Monte Rosa Therapeutics
Chicago Atlantic Real Estate Finance press release ( REFI ): Q1 GAAP EPS of $0.46 beats by $0.02 . Net interest income of $13.12M (+0.6% Y/Y) misses by $1.07M . The Company expects to maintain a dividend payout ratio based on Distributable Earnings per weighted average diluted share of approximately 90% to 100% on a full year basis. More on Chicago Atlantic Real Estate Finance Chicago Atlantic Rea...
Chicago Atlantic Real Estate Finance press release ( REFI ): Q1 GAAP EPS of $0.46 beats by $0.02 . Net interest income of $13.12M (+0.6% Y/Y) misses by $1.07M . The Company expects to maintain a dividend payout ratio based on Distributable Earnings per weighted average diluted share of approximately 90% to 100% on a full year basis. More on Chicago Atlantic Real Estate Finance Chicago Atlantic Real Estate Finance: 15% Dividend Yield, But A Cautious Allocation Chicago Atlantic Real Estate Finance, Inc. 2025 Q4 - Results - Earnings Call Presentation Chicago Atlantic Real Estate Finance, Inc. (REFI) Q4 2025 Earnings Call Transcript Chicago Atlantic Real Estate Finance declares $0.47 dividend Chicago Atlantic outlines $616M pipeline expansion as lending discipline holds amid cannabis reform momentum
WEST PALM BEACH, Fla., May 07, 2026 (GLOBE NEWSWIRE) -- Advanced Flower Capital Inc. (Nasdaq: AFCG) (“AFC,” or the “Company”) today announced its financial results for the first quarter ended March 31, 2026.
WEST PALM BEACH, Fla., May 07, 2026 (GLOBE NEWSWIRE) -- Advanced Flower Capital Inc. (Nasdaq: AFCG) (“AFC,” or the “Company”) today announced its financial results for the first quarter ended March 31, 2026.
Acacia Research press release ( ACTG ): Q1 Non-GAAP EPS of -$0.07 beats by $0.02 . Revenue of $54.2M (-56.4% Y/Y) beats by $4.2M . Total Company Adjusted EBITDA 1 of $1.6 million and Operated Segment Adjusted EBITDA 1 of $6.8 million for the Quarter Total Cash, Cash Equivalents, Equity Securities Measured at Fair Value and Loans Receivable of $329.9 million, or $3.41 per share More on Acacia Resea...
Acacia Research press release ( ACTG ): Q1 Non-GAAP EPS of -$0.07 beats by $0.02 . Revenue of $54.2M (-56.4% Y/Y) beats by $4.2M . Total Company Adjusted EBITDA 1 of $1.6 million and Operated Segment Adjusted EBITDA 1 of $6.8 million for the Quarter Total Cash, Cash Equivalents, Equity Securities Measured at Fair Value and Loans Receivable of $329.9 million, or $3.41 per share More on Acacia Research Acacia Research Corporation (ACTG) Q4 2025 Earnings Call Transcript Acacia Research Corporation 2025 Q4 - Results - Earnings Call Presentation Acacia Research Q1 2026 Earnings Preview Small-cap financial stocks split on quant ratings ahead of Q1 earnings Seeking Alpha’s Quant Rating on Acacia Research
Investor Ross Gerber of the investment firm Gerber Kawasaki has urged drivers to opt for EVs in view of the Iran war that has led to surging gas prices across the U.S. Gas Prices Won’t Come Down In a post on X on Tuesday, Gerber outlined the benefits of EVs over gasoline-powered vehicles. “Gas prices don't matter to the 10 mil people that own a tesla,” he said in the post. He added that there were...
Investor Ross Gerber of the investment firm Gerber Kawasaki has urged drivers to opt for EVs in view of the Iran war that has led to surging gas prices across the U.S. Gas Prices Won’t Come Down In a post on X on Tuesday, Gerber outlined the benefits of EVs over gasoline-powered vehicles. “Gas prices don't matter to the 10 mil people that own a tesla,” he said in the post. He added that there were several options for “great EVs” available from dealers, as well as in the used markets. “Go get one